Lipidor Ab (LIPI) - Total Liabilities

Latest as of December 2024: Skr3.86 Million SEK ≈ $415.29K USD

Based on the latest financial reports, Lipidor Ab (LIPI) has total liabilities worth Skr3.86 Million SEK (≈ $415.29K USD) as of December 2024. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore cash efficiency ratio of Lipidor Ab to assess how effectively this company generates cash.

Lipidor Ab - Total Liabilities Trend (2016–2024)

This chart illustrates how Lipidor Ab's total liabilities have evolved over time, based on quarterly financial data. See Lipidor Ab (LIPI) shareholders funds for net asset value and shareholders' equity analysis.

Lipidor Ab Competitors by Total Liabilities

The table below lists competitors of Lipidor Ab ranked by their total liabilities.

Company	Country	Total Liabilities
Pasithea Therapeutics Corp NASDAQ:KTTA	USA	$1.42 Million
Ordinary Fully Paid Deferred Settlement AU:88EDA	Australia	AU$356.79K
Uniserve Communications Corp V:USS	Canada	CA$3.45 Million
Catenon S.A MC:COM	Spain	€2.60 Million
Higher Way Electronic Co Ltd TWO:3268	Taiwan	NT$548.21 Million
Tuju Setia Bhd KLSE:5297	Malaysia	RM447.21 Million
Smithson Investment Trust PLC LSE:SSON	UK	GBX1.63 Million
Indivior PLC LSE:INDV	UK	GBX1.71 Billion

Liability Composition Analysis (2016–2024)

This chart breaks down Lipidor Ab's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Lipidor Ab market cap and net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.92	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.50	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.33	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Lipidor Ab's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Lipidor Ab (2016–2024)

The table below shows the annual total liabilities of Lipidor Ab from 2016 to 2024.

Year	Total Liabilities	Change
2024-12-31	Skr3.86 Million ≈ $415.29K	-68.27%
2023-12-31	Skr12.16 Million ≈ $1.31 Million	-9.74%
2022-12-31	Skr13.47 Million ≈ $1.45 Million	+17.22%
2021-12-31	Skr11.49 Million ≈ $1.24 Million	+417.33%
2020-12-31	Skr2.22 Million ≈ $239.12K	+50.95%
2019-12-31	Skr1.47 Million ≈ $158.41K	-60.60%
2018-12-31	Skr3.74 Million ≈ $402.05K	+239.33%
2017-12-31	Skr1.10 Million ≈ $118.49K	-34.73%
2016-12-31	Skr1.69 Million ≈ $181.53K	--

About Lipidor Ab

ST:LIPI Sweden Drug Manufacturers - General

Market Cap

$18.82 Million

Skr174.88 Million SEK

Market Cap Rank

#25226 Global

#514 in Sweden

Share Price

Skr0.22

Change (1 day)

+0.00%

52-Week Range

Skr0.22 - Skr0.30

All Time High

Skr22.60